FIELD: pharmacy.
SUBSTANCE: invention provides a pharmaceutical composition which is a single-dose dosage form comprising a compartment containing olmesartan medoxomil and a compartment comprising rosuvastatin or its salt, wherein the said compartments are formed in the isolated form. The compartment containing olmesartan medoxomil comprises from 7.5 to 65 wt % of hydroxypropylcellulose with a low degree of substitution. The compartment comprising rosuvastatin or its salt includes one or more disintegrants selected from the group consisting of crospovidone, hydroxypropyl cellulose with a low degree of substitution, croscarmellose sodium and carboxymethylcellulose calcium. The disintegrant in the said compartment with rosuvastatin is present in the amount of from 2 to 20 wt %. The pharmaceutical composition is a bilayer tablet or a capsule containing granules. The pharmaceutical composition of the present invention solves the problem of slowing down the absorption associated with drug-drug interactions.
EFFECT: combination drug of the present invention is bioequivalent to mono-preparation of each of the said drugs.
6 cl, 6 dwg, 16 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMBINATION PREPARATION CONTAINING THE INHIBITOR OF HMG-CoA REDUCTASE AND INHIBITOR OF CHOLESTEROL ABSORPTION | 2014 |
|
RU2649811C2 |
PHARMACEUTICAL COMBINED DRUG | 2014 |
|
RU2639818C2 |
PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-CoA REDUCTASE INHIBITOR | 2014 |
|
RU2662565C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIMICROBIAL ACTION, AND METHOD FOR PREPARING IT | 2012 |
|
RU2497501C1 |
PHARMACEUTICAL PREPARATION | 2019 |
|
RU2756452C1 |
METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
FILM COATED TABLET CONTAINING CHOLINE ALFOSCERATE AND PROCESS FOR PREPARING SAME | 2014 |
|
RU2669351C1 |
COMBINED COMPOSITION CONTAINING METFORMIN OF SUSTAINED RELEASE AND INHIBITOR HMG-CoA-REDUCTASE OF IMMEDIATE RELEASE | 2014 |
|
RU2651460C2 |
DRUG COMPOSITION INCLUDING SGLT-2 INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER | 2018 |
|
RU2778313C2 |
HYPOLIPIDEMIC DOSAGE FORM AND METHOD FOR PREPARING IT | 2013 |
|
RU2547574C2 |
Authors
Dates
2017-04-17—Published
2013-03-22—Filed